270 related articles for article (PubMed ID: 10377335)
1. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.
Van Wagoner NJ; Oh JW; Repovic P; Benveniste EN
J Neurosci; 1999 Jul; 19(13):5236-44. PubMed ID: 10377335
[TBL] [Abstract][Full Text] [Related]
2. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes.
Kordula T; Rydel RE; Brigham EF; Horn F; Heinrich PC; Travis J
J Biol Chem; 1998 Feb; 273(7):4112-8. PubMed ID: 9461605
[TBL] [Abstract][Full Text] [Related]
6. Cytokine regulation of CC and CXC chemokine expression by human astrocytes.
Oh JW; Schwiebert LM; Benveniste EN
J Neurovirol; 1999 Feb; 5(1):82-94. PubMed ID: 10190694
[TBL] [Abstract][Full Text] [Related]
7. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
8. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.
Hurst SM; McLoughlin RM; Monslow J; Owens S; Morgan L; Fuller GM; Topley N; Jones SA
J Immunol; 2002 Nov; 169(9):5244-51. PubMed ID: 12391243
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6.
Sawada S; Chosa N; Ishisaki A; Naruishi K
Biomed Res; 2013 Feb; 34(1):31-40. PubMed ID: 23428978
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE
Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of interleukin-1- and tumor necrosis factor alpha-dependent regulation of the alpha 1-antichymotrypsin gene in human astrocytes.
Kordula T; Bugno M; Rydel RE; Travis J
J Neurosci; 2000 Oct; 20(20):7510-6. PubMed ID: 11027208
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells.
Holub MC; Hegyesi H; Igaz P; Polgár A; Toth S; Falus A
Immunol Lett; 2002 Jun; 82(1-2):79-84. PubMed ID: 12008038
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
Ringheim GE; Szczepanik AM; Petko W; Burgher KL; Zhu SZ; Chao CC
Brain Res Mol Brain Res; 1998 Mar; 55(1):35-44. PubMed ID: 9645958
[TBL] [Abstract][Full Text] [Related]
15. IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression.
Suzuki M; Hashizume M; Yoshida H; Shiina M; Mihara M
Cytokine; 2010 Aug; 51(2):178-83. PubMed ID: 20403707
[TBL] [Abstract][Full Text] [Related]
16. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
[TBL] [Abstract][Full Text] [Related]
17. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes.
Shrikant P; Chung IY; Ballestas ME; Benveniste EN
J Neuroimmunol; 1994 May; 51(2):209-20. PubMed ID: 7910170
[TBL] [Abstract][Full Text] [Related]
18. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.
Aloisi F; Carè A; Borsellino G; Gallo P; Rosa S; Bassani A; Cabibbo A; Testa U; Levi G; Peschle C
J Immunol; 1992 Oct; 149(7):2358-66. PubMed ID: 1382099
[TBL] [Abstract][Full Text] [Related]
19. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.
Hooper WC; Phillips DJ; Evatt BL
Thromb Haemost; 1997 May; 77(5):1014-9. PubMed ID: 9184420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
